Weight-loss patients voice concerns as CVS Caremark drops Zepbound coverage for Wegovy, though exceptions may exist for those ...

Oral GLP-1 drugs will fill a niche rather than displace injections, according to analysts. TD Cowen estimates that pills will ...

Makers of weight-loss drugs are expected to rake in more than $150 billion in revenue by the early 2030s, thanks to the ...

Doctors suggest that anybody with a Body mass index of over 30 or greater than 27 is advised to try weight loss drugs.

Tricare officials said the Defense Health Agency is eliminating coverage for its Tricare for Life beneficiaries and others to ...

Just like when you find a glitzy resort in your dream destination, your first question about weight loss drugs might be, how ...

Tennis legend Serena Williams is sharing her journey with weight loss drugs, saying she's lost 31 pounds in 8 months using ...

Doctors advise most patients on GLP-1 obesity drugs such as Wegovy and Zepbound to stay on them to keep the weight off, but ...

Eli Lilly shares fell after the company’s oral drug showed less weight loss than hoped. It could still be huge.

Since DeMore started Mounjaro, another drug, Zepbound, which has the same active ingredient, called tirzepatide, has been approved for weight loss, joining Wegovy as an approved weight loss ...

People taking Eli Lilly's obesity drug, Zepbound, lost nearly 50% more weight than those using rival Novo Nordisk's Wegovy in the first head-to-head study of the blockbuster medications. Clinical ...

DeMore talked to her doctor about getting on Mounjaro, a diabetes medication being used off-label by some for weight loss. "I've lost 93 pounds since March, and I feel absolutely amazing.